GenScript Biotech sets up new operations and logistics hub in Australia

GenScript Biotech Corporation, a global leader in life sciences services and products, has announced the establishment o...

November 12, 2024 | Tuesday | News
Avance Clinical’s CEO Yvonne Lungershausen on Expanding Footprint in Asia-Pacific: A Strategic Focus on South Korea’s Clinical Excellence

In a recent conversation with Ankit Kankar from BioSpectrum Asia, Yvonne Lungershausen, CEO of Avance Clinical, shared i...

November 11, 2024 | Monday | News
Australia establishes new international research lab to tackle treatment-resistant cancer

The University of Melbourne and France's National Centre for Scientific Research (CNRS) will establish a new Internation...

November 8, 2024 | Friday | News
AusBiotech and LSQ to strengthen national life sciences sector

AusBiotech, Australia’s leading national industry body representing more than 3,000 life sciences members, and Lif...

November 11, 2024 | Monday | News
Monash and Apollo Hospitals join hands to progress digital health research

Australia-based Monash University’s Faculty of Information Technology has partnered with Apollo Hospitals - one of...

November 6, 2024 | Wednesday | News
Biomedical engineers in Australia design high-speed 3D bioprinter as gamechanger for drug discovery

Biomedical engineers from the University of Melbourne, Australia have invented a 3D printing system, or bioprinter, capa...

November 4, 2024 | Monday | News
Australia enhances national skin cancer screening with $10.3 M investment

The Albanese Government is investing $10.3 million to tackle the most common cancer in the sunburnt country, skin cancer...

October 31, 2024 | Thursday | News
“The Vietnam Institute is set to play a key role in fostering regional collaborations by acting as a hub for knowledge exchange and partnerships”

What was the rationale behind choosing Vietnam as the location for this institute, and how does the country’s acad...

October 31, 2024 | Thursday | Opinion
“Australia is a great place to do business as we have a superb research community, great partners and very experienced clinical trial units”

Tell us about Noxopharm and its portfolio of innovative treatments.  We are an Australian biotech with two highly ...

October 31, 2024 | Thursday | Opinion
“Moving forward, cancer may not be a death threat but a manageable disease with strong control”

Could you explain more about the advantages of using iPSCs from cord blood for creating your ‘off-the-shelf’...

October 31, 2024 | Thursday | Opinion
Avance Clinical Strengthens Asia-Pacific Presence with Strategic MoUs in South Korea for Enhanced Clinical Research Solutions

Avance Clinical, a leading full-service Contract Research Organization (CRO), has announced three pivotal Memorandums of...

October 30, 2024 | Wednesday | News
Australia's Vaxxas licenses next-gen vaccine for Respiratory Syncytial Virus from NIH

Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density microarray patc...

October 29, 2024 | Tuesday | News
Seaport Therapeutics secures $225 M funding to develop neuropsychiatric medicines using prodrug technology

The clinical-stage biopharmaceutical company, Seaport Therapeutics, which uses a unique drug delivery platform orig...

October 26, 2024 | Saturday | News
Australia's Telix spins off Rhine Pharma to expand global access to radiopharmaceuticals

Australia-based Telix Pharmaceuticals has announced the spin-off of Rhine Pharma, which has the mission of expanding glo...

October 23, 2024 | Wednesday | News
Aidoc and Integral Diagnostics expand AI partnership in Australia and New Zealand

Aidoc, a global pioneer in clinical artificial intelligence (AI) solutions, has announced the expansion of its partnersh...

October 15, 2024 | Tuesday | News
Australian partnership working towards Universal Health in the Philippines

University of Adelaide’s Joanna Briggs Institute (JBI) is working with the Australia Awards Fellowships to he...

October 12, 2024 | Saturday | News
$18 M investment for world-first Australian research project for heart attack protection

The government is investing almost $18 million in a world-first Australian research project that will trial a drug disco...

October 7, 2024 | Monday | News
Indian medtech firm SMT gets Australian approval for drug-eluting stent Supraflex Cruz

SMT (Sahajanand Medical Technologies), a global leader in innovative medical devices based in India, has announced that ...

September 28, 2024 | Saturday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls